12/18/2025 11:00
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in seri...

AFP Joins the New Phase of the German-language Platform Against Disinformation, GADMO 2.0

Three years after its launch, GADMO (the German-Austrian Digital Media Observatory) — the largest German-language fact-checking network bringing together journalists and researchers — is entering a new phase aimed at reaching a wider audience, with the support of the European Commission.

Three years after its launch, GADMO (the German-Austrian Digital Media Observatory) — the largest German-language fact-checking network bringing together journalists and researchers — is entering a new phase aimed at reaching a wider audience, with the support of the European Commission.
12/25/2025 11:34
Hanshow and the University of Cambridge Launch Joint Research on Augmented Intelligent Hybrid Wireless Technology

Hanshow, a global leader in electronic shelf labels (ESL) and digital store solutions, has entered into a multi-year research collaboration with the University of Cambridge, one of the world’s most prestigious academic institutions. The partnership will focus on joint research and innovation in next-generation intelligent hybrid wireless technologies, marking an important milestone in Hanshow’s continued investment in core technologies and long-term innovation. This press release features mult...

Subscribe to